These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15721391)

  • 1. Delivery of antiviral agents in liposomes.
    Düzgüneş N; Simões S; Slepushkin V; Pretzer E; Flasher D; Salem II; Steffan G; Konopka K; Pedroso de Lima MC
    Methods Enzymol; 2005; 391():351-73. PubMed ID: 15721391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
    Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes.
    Düzgünes N; Simões S; Slepushkin V; Pretzer E; Rossi JJ; De Clercq E; Antao VP; Collins ML; de Lima MC
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):515-23. PubMed ID: 11563068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.
    Düzgüneş N; Pretzer E; Simões S; Slepushkin V; Konopka K; Flasher D; de Lima MC
    Mol Membr Biol; 1999; 16(1):111-8. PubMed ID: 10332745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
    Fattal E; Couvreur P; Dubernet C
    Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in antisense efficacy and delivery.
    Agrawal S; Akhtar S
    Trends Biotechnol; 1995 Jun; 13(6):197-9. PubMed ID: 7598842
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro.
    Valiaeva N; Beadle JR; Aldern KA; Trahan J; Hostetler KY
    Antiviral Res; 2006 Oct; 72(1):10-9. PubMed ID: 16630664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests.
    AIDS Patient Care STDS; 1996 Dec; 10(6):375-6. PubMed ID: 11361558
    [No Abstract]   [Full Text] [Related]  

  • 10. Sense antisense nonantisense. Can these novel antivirals knock HIV senseless?
    Chang HE; Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Feb; 1(1):11-8. PubMed ID: 11362229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
    Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
    J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E; Holý A
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 infection: is it time to reconsider our concepts?
    Krambovitis E; Spandidos DA
    Int J Mol Med; 2006 Jul; 18(1):3-8. PubMed ID: 16786149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral evaluation of novel cyclopropyl nucleosides, phosphonate nucleosides and phosphonic acid nucleosides.
    Hyun Oh C; Hong JH
    Arch Pharm (Weinheim); 2006 Sep; 339(9):507-12. PubMed ID: 16795106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl nucleoside H-phosphonates. Part 16: synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters.
    Romanowska J; Szymańska-Michalak A; Boryski J; Stawiński J; Kraszewski A; Loddo R; Sanna G; Collu G; Secci B; La Colla P
    Bioorg Med Chem; 2009 May; 17(9):3489-98. PubMed ID: 19282192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies towards HIV-1 infection in macrophages.
    Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
    Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
    Williamson MP; McCormick TG; Nance CL; Shearer WT
    J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.
    Venugopalan P; Jain S; Sankar S; Singh P; Rawat A; Vyas SP
    Pharmazie; 2002 Oct; 57(10):659-71. PubMed ID: 12426945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and optimisation of potent gp120-CD4 inhibitors.
    Tran TD; Adam FM; Calo F; Fenwick DR; Fok-Seang J; Gardner I; Hay DA; Perros M; Rawal J; Middleton DS; Parkinson T; Pickford C; Platts M; Randall A; Stephenson PT; Vuong H; Williams DH
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5250-5. PubMed ID: 19632839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.